Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000912282-12-000119
Filing Date
2012-02-08
Accepted
2012-02-08 13:39:16
Documents
3
Period of Report
2012-02-08

Document Format Files

Seq Description Document Type Size
1 oncolytics6k_02082012.htm 6-K 23338
2 PRESS RELEASE DATED FEBRUARY 8, 2012 ex99_1.htm EX-99.1 16741
3 oncolytics_logo.jpg GRAPHIC 12620
  Complete submission text file 0000912282-12-000119.txt   58610
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 12580956
SIC: 2834 Pharmaceutical Preparations